Tag Archives: patients

FDA Approves Broadened Indication for Xeomin (incobotulinumtoxinA) as First-Line Treatment for Blepharospasm (Involuntary Blinking) in Adult Patients

Print this page RALEIGH, N.C.  –  May 13,  2019  –  Merz Americas announced today that the U.S. Food and Drug Administration (FDA) has approved the supplemental Biologics License Application (sBLA) for Xeomin (incobotulinumtoxinA), broadening its indication to be a first-line treatment of blepharospasm (involuntary blinking) in adult patients. “Merz is proud to offer a first-line… Read More »

Info for nearly 1M patients exposed on UW Medicine web server

A vulnerability on a website server at UW Medicine in Washington has resulted in a large data breach, affecting the records of nearly 1 million patients. A forensic investigation at the organization said information was exposed to the public through the vulnerability, although the most sensitive protected health information, including Social Security numbers, were not… Read More »